Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Three cases (one, newborn infant and two infants--one of them recently published--) who present electrocardiographic and enzymatic alterations comparative with diagnosis of
ischemia
and myocardial infarction are reported. Rarity of this entity in infants is stressed as most of published cases are secondary to ananomolous coronary artery. Etiology of the cases presented shows a myocardiac fibrosis with Schwachman's syndrome in one case, a coronary thrombosis secondary to a
disseminated intravascular coagulation
in a second case, and finally a generalized hypoplasia of coronary arteries. Hypoxia appears in these cases a factor acting in favour of myocardial ischemia. Diagnostic criteria of acute myocardial infarction are based on typical electrocardiogram and rise of isoenzymes of LDH and CPK-MB. Although rare, it is a diagnosis to be considered in cases of unknow cardiac insufficiency in newborns and infants.
...
PMID:[Myocardial infarction and myocardial ischemia in newborn children and infants, not secondary to an abnormal coronary]. 666 Jun 44
The clinical courses in 39 children with NEC were studied to answer questions about pathogeny and the indication for surgical treatment. Anamnestic, clinical and hematological findings show an
ischemia
to be the "conditio sine qua non".
Disseminated intravascular coagulation
does not seem to be the primary cause of the disease. Whether bacterial infections of the intestinal wall are of importance in the pathogeny cannot sufficiently be proven on the available findings. The clinical symptoms, the number of platelets and the level of serum-sodium make it possible to classify NEC in four stages with typical morphologic appearance. The results of an early and of a late treatment by operation are compared and it is deduced that the best moment for surgical intervention will be the change from stage II to stage III. Symptoms of stages II/III are the progressive clinical course with increasing intestinal bleeding, edema of the abdominal wall and scrotum, thrombopenia and low sodium level.
...
PMID:[Necrotizing enterocolitis (NEC) - pathogenesis and therapy (author's transl)]. 728 80
Multiple extremity gangrene developed in five patients as a complication of dopamine therapy. The clinical conditions were (1) penetrating chest trauma requiring pneumonectomy with postoperative sepsis, (2) cardiac arrest with aspiration pneumonia, (3) lymphoma with sepsis, (4) Klebsiella pneumonia, and (5) myocardial infarction. The development of acrocyanosis leading to gangrene occurred at dopamine dosages of 5.1 to 10.2 micrograms/kg/min. The alpha-adrenergic vasoconstriction effects of dopamine would not be expected from the doses employed in these patients. Thus, other factors beside pure alpha vasoconstriction are responsible for tissue necrosis after the use of dopamine. We believe that the embolic complications of
disseminated intravascular coagulation
and hypovolemia are serious risk factors in the development of dopamine gangrene. Peripheral vasoconstriction from dopamine, even at low doses, may set the stage for thrombotic complications of
disseminated intravascular coagulation
and lead to tissue damage. In laboratory models of
disseminated intravascular coagulation
, an alpha-adrenergic drug is required to produce peripheral ischemic tissue damage. Treatment of tissue
ischemia
related to dopamine depends on early recognition of acrocyanosis. Phentolamine, an alpha blocker, has been recommended for treating dopamine
ischemia
, either through local instillation into ischemic tissues or intravenous infusion. We recommend a high index of suspicion for, and early treatment of, underlying consumptive coagulopathy in all patients requiring dopamine.
...
PMID:Dopamine gangrene. Association with disseminated intravascular coagulation. 730 16
A 34-year old woman, with a 3 yr history of severe seropositive rheumatoid arthritis (RA) with lupus anticoagulant and anticardiolipin antibodies, developed a massive anterior myocardial infarction and
ischemia
of the lower extremities, with
disseminated intravascular coagulation
resulting from extensive tissue damage. Seven days after admission, she died of severe heart failure complicated by ventricular fibrillation. To our knowledge, this is the first documented case of fatal acute antiphospholipid syndrome in RA.
...
PMID:Catastrophic antiphospholipid syndrome with fatal acute course in rheumatoid arthritis. 747 89
Retinal detachment is a rare complication of preeclampsia, eclampsia and abruptio placentae. We report a case of bilateral retinal detachment in association with severe preeclampsia complicated with abruptio placentae, intrauterine fetal death and
disseminated intravascular coagulation
. In obstetric complications, placental thromboplastin may release into maternal circulation and activate the extrinsic coagulation system with resultant
disseminated intravascular coagulation
. This may be responsible for choroidal
ischemia
and consequent serous retinal detachment.
...
PMID:Retinal detachment in association with preeclampsia and abruptio placentae. 763 40
Defibrotide is a polydeoxyribonucleotide-derived anti-ischemic drug with multiple sites of action involving both plasmatic and cellular targets. This agent has been demonstrated to produce profibrinolytic, cytoprotective, and vaso-facilatory actions. Since monocytes are increased in the mediation of some of the pathophysiologic responses seen in ischemic disorders, the functional properties of these cells were investigated in experimental conditions to evaluate their behavior during resting and stimulated states. Defibrotide was supplemented in these systems to determine its modulatory action. In this investigation Defibrotide was found to decrease the PAI-1 levels and may indicate that this may be the mechanism for its profibrinolytic actions. Defibrotide was also found to reduce the procoagulant activity of monocytes in these experimental settings. Both PAI and procoagulant factors play an important role in the pathophysiology of inflammation,
DIC
, and
ischemia
. Defibrotide induced reduction of these two factors represents the mechanism whereby this agent produces its therapeutic action.
...
PMID:Defibrotide reduces monocyte PAI-2 and procoagulant activity. 766 Jan 47
The inflammatory/immune response is designed to protect the body and limit the extent of injury. In the setting of critical illness, however, regulation of this exquisite response is often lost for reasons that remain to be elucidated. Loss of regulation combined with shock, infection, inflammation, and/or
ischemia
often leads to the development of the systemic inflammatory response syndrome (SIRS), which frequently is associated with the development of septic shock,
disseminated intravascular coagulation
(
DIC
), multiple organ dysfunction (MODS), and other complications of critical illness.
...
PMID:The inflammatory/immune response in critical illness: role of the systemic inflammatory response syndrome. 794 86
This paper describes the main pathophysiological events leading to multiple organ failure (MOF) related to
disseminated intravascular coagulation
(
DIC
), caused by circulatory failure or infection. The main mechanisms responsible for the development of MOF in
DIC
are discussed, as are both the organ
ischemia
due to stasis and/or obstruction and the close interrelated reactions between inflammatory reaction, immune system and coagulation systems, especially focused on the close connection between the endothelium and superimposed mediators.
...
PMID:[Multiple organ failure related to disseminated intravascular coagulation]. 843 24
A case of multicystic encephalomalacia in a twin is reported. The other twin died in utero at 32 weeks gestational age. Because there was no evidence of fetal distress the pregnancy was allowed to continue until 36 weeks gestational age. Injuries to the surviving twin due to
disseminated intravascular coagulation
(DIVC) and vascular thrombosis or to anoxia and
ischemia
may occur when there are anastomoses between the circulatory systems of the two twins, i.e., in monochorionic pregnancies. The classically recommended strategy is to wait for adequate maturity of the surviving fetus (36 weeks). It is suggested that this attitude may be overly expectant and may deserve reappraisal.
...
PMID:[Multicystic encephalomalacia in a surviving twin after death of the other twin in utero]. 844 44
Although rare, exertional collapse and sudden death are the most serious potential complications of sickle cell trait. Studies suggest that this condition may occur in susceptible persons when poor physical conditioning, dehydration, heat stress or hypoxic states precipitate sickling of the abnormal erythrocytes. Sickling leads to endothelial damage, which can cause vasoconstriction,
disseminated intravascular coagulation
and local tissue damage. Cardiac effects include acute
ischemia
and arrhythmias. Muscle damage results in acute compartment syndromes and release of myoglobin into the circulation. Acute renal failure is possible. Diagnosis is based on a high index of suspicion, and characteristic presentation and laboratory findings, including myoglobinuria, hyperkalemia, hypocalcemia, hyperphosphatemia and elevated creatine kinase levels. The differential diagnosis includes pulmonary embolism, acute cardiac events, anaphylaxis and heat stroke. Management is based on stabilization, rehydration, and the treatment and prevention of complications.
...
PMID:Exertional collapse and sudden death associated with sickle cell trait. 904 99
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>